Fetal stem cell transplantation and gene therapy.
A-thalassemia
Fetal therapy
Gene therapy
Hematopoetic stem cell
Mesenchymal stem cells
Osteogenesis imperfecta
Journal
Best practice & research. Clinical obstetrics & gynaecology
ISSN: 1532-1932
Titre abrégé: Best Pract Res Clin Obstet Gynaecol
Pays: Netherlands
ID NLM: 101121582
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
01
11
2018
accepted:
26
02
2019
pubmed:
27
3
2019
medline:
1
2
2020
entrez:
27
3
2019
Statut:
ppublish
Résumé
The present chapter summarizes our current knowledge on fetal stem cell and gene therapy. It focuses on these therapeutic alternatives in regard to past experiences and ongoing and planned studies in humans. Several methodological challenges are discussed that may have wide implications on how these methods could be introduced in clinical practices. Although still promising, the methods are afflicted with very special requirements not least in regard to safety and ethical questions. Furthermore, careful monitoring and extended follow-up of the child and his/hers mother who receive prenatal stem cell or gene treatments are of outmost importance. Taken these prerequisites into consideration, it is natural that this type of experimental fetal therapies requires collaboration between different disciplinaries and institutions within medicine.
Identifiants
pubmed: 30910447
pii: S1521-6934(18)30243-8
doi: 10.1016/j.bpobgyn.2019.02.007
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
142-153Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.